FindTrial
Sign In

Comparision of two different approaches,lateral and Classical of supraclavicular brachial plexus block with 0.5% ropivacaine drug.

A Comparative clinical study for efficacy of Lateral and Classical approach of supra clavicular brachail plexus block with 0.5% Ropivacaine in upper limb surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046575
Enrollment
108
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Lateral and Classical approach of supra clavicular brachial plexus block.: comparative clinical study of efficacy for lateral and classical approach of supraclavicular brachial plexus b

Sponsors

department of anesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • ASA grade I and II. • Both sex of age group >18yr • Undergoing surgery for elective and emergency

Exclusion criteria

Exclusion criteria: •Age •History of allergy to local anaesthetic agent. •Bleeding disorders •History of significant psychiatric problem •Parturient and lactating women •Infection at the puncture site

Design outcomes

Primary

MeasureTime frame
â?¢ Lateral approach is :- Maximum Safe More reliable More efficacious Timepoint: 20 months—

Secondary

MeasureTime frame
higher success rate of lateral approchTimepoint: 24 weeks—

Countries

India

Contacts

Public ContactDr Mahesh Kumar Vishwakarma

GAJRA RAJA MEDICAL COLLEGE GWALIOR MP

drpreetiravigoyal@gmail.com9424455330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026